Safe, Effective, and More Tolerable 16 Tablets Colon Prep (ABP)

January 6, 2009 updated by: Long Neck Medical Enterprises

Phase III of the AB Prep Safety and Efficacy in Colon Cleansing

The purpose of this study is determine if the AB Prep (a 16 tablets colon cleansing prep), is an effective, and safe colon cleansing prep in preparation for colonoscopy, and severe constipation.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

The available colon cleansing preps have issues with patient's tolerance( Abdominal pain, nausea, vomiting), and as recently noted by the FDA safety issues such a change in EKG, blood electrolytes requiring 72 hours to correct, and most recently PO4 nephropathy.

The AB Prep is a 16 tablets prep that has excellent patient's tolerance efficacy, with no change in blood electrolytes or EKG. ( PhaseI (20 patients) and Phase II (200 patients)

The protocol that was used is as follows:

(IND application # 75,704)

Protocol design for testing the safety and efficacy of the AB Prep:

The AB Prep is a combination of 2 Reglan tablets (10mg each), 6 Dulcolax tablets, and 8 K-Phos Neutral tablets. The combination is given in two steps, four hours apart; the day before the colonoscopy.

As before, the objective of this clinical trial is to examine the AB Prep first and foremost for safety, and second for efficacy of colon cleansing.

The proposed trial is for One-Arm Study of subjects undergoing elective and therapeutic colonoscopy.

Phase III: 400 patients, The selection will be random, the age probably ranging from 12 to 75 years old.

The patients will have a Pre, and post procedural EKG, comprehensive (Sodium, Potassium, Creatinine, BUN, Calcium, Magnesium, Phosphate, Glucose), and vital signs.

The patients with severe constipation (One bowel movement per week or more) will not be included in the study. (In our experience, those people required two days prep to achieve colon cleansing).

The SRSS statistical program will be used for data collection and analysis:

The end point of the study is colon cleansing, adequate enough to perform colonoscopy. The colon cleansing will be graded as follow:

  1. Poor colon prep, unable to proceed with colonoscopy.
  2. Able to do colonoscopy with, the colon cleansing labeled as:

A- Excellent, Totally cleansed B- Good, adequately cleansed, with need for irrigation.

In addition to efficacy, we would like to check for patient's satisfaction and compliance, (Most common complaints that the patients tend to voice with the present approved colon preps).

Patient's satisfaction data will be collected before the procedure and will be graded as follow:

  1. Totally satisfied with the Prep, without any complaints
  2. Satisfied, with the following complaints (Nausea, vomiting, abdominal pain/cramping)
  3. Unsatisfied with the Prep (Reasons!!!)

Patient's compliance will be graded as follow:

  1. Compliant
  2. Non compliant(Reasons).

The prep instruction will be as follows REPARATION FOR COLONOSCOPY

FIVE DAYS before your procedure:

  1. If you take COUMADIN or PLAVIX, we recommend that you stop these medications. You must contact your primary care physician or cardiologist for specific instructions. You may restart these medications again after the procedure unless otherwise instructed.
  2. If you have DIABETES and take medication to control your blood sugar, contact your primary care physician or diabetes doctor for instructions about how to take your diabetes medication while preparing for this procedure.
  3. Stop taking iron or multivitamins that contain iron.
  4. Avoid the use of aspirin and aspirin-like medications such as ibuprofen, Advil and Aleve. These medicines may increase your risk of bleeding after polyp removal.
  5. Start a low-roughage diet and do not eat corn or raw vegetables. You may re-start your usual diet after the procedure.

TWO DAYS before the procedure:

1. Take 2 tablets of Dulcolax at 8:00 PM.

ONE DAY before the procedure:

  1. Begin a clear liquid diet at breakfast and continue this diet until 4 hours before your procedure. A clear liquid diet includes: water, tea, black coffee, clear broth, apple juice, white grape juice, Gatorade, soda, Jell-O. Do not eat or drink anything red, including red Jell-O. Do not drink milk. Do not use sugar-free drinks. All patients, including those with DIABETES, should be sure they get enough sugar during this time.
  2. At 8:00 AM, take One Reglan(10mg) tablet, 2 Dulcolax tablets, and 4 tablets of K-PHOS NEUTRAL. Drink three glasses of water/juice SLOWLY over 1 hour. The laxative effect begins in about 2 hours. BE SURE TO DRINK AT LEAST 3 GLASSES OF WATER OR JUICE AFTER TAKING EACH DOSE OF THE prep.( Each Glass =350cc)
  3. At 12:00 Noon, Take 2 Dulcolax tablets and 4 tablets of K-PHOS NEUTRAL, along with 3 glasses of water/Juice.(Each glass =350cc).

ON THE DAY of your procedure:

  1. Take all of your usual medicines and 1 tablet of Reglan (10mg). Do Not Take Coumadin, Plavix, or Aspirin. If you take INSULIN, take 1/2 your usual dose.
  2. If you have a medical condition requiring antibiotics before or after procedures, we will determine whether they are needed for your colonoscopy.
  3. STOP CLEAR LIQUIDS 4 HOURS BEFORE YOUR PROCEDURE (except for small amount of water with medications). DO NOT EAT OR DRINK ANYTHING UNTIL AFTER YOUR PROCEDURE.
  4. Wear loose-fitting, comfortable clothes.
  5. Read the consent form. You will be asked to sign the form before your procedure.

Please bring these things WITH YOU to your procedure:

  1. A list of all of your medications, including the doses
  2. Your identification or insurance card
  3. The name and phone number of your escort.

AFTER your procedure:

  1. You will be monitored in the Endoscopy Unit recovery area for 20-30 minutes.
  2. You may have some abdominal bloating after the procedure. It should resolve within an hour.

4. You may eat your normal diet after the procedure.

5. You may return to work the day after the procedure.

HELPFUL HINTS FOR PATIENTS UNDERGOING COLONOSCOPY

1.Use moist wipes (baby wipes) instead of toilet paper.

Study Type

Observational

Enrollment (Anticipated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Delaware
      • Millsboro, Delaware, United States, 19966
        • Cedar Tree Surgical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 75 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Any patient between the age of 12 and 75, who is eligible for colonoscopy.

Description

Inclusion Criteria:

  • Any eligible patient for colonoscopy

Exclusion Criteria:

  • Patients with renal failure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
PREVENTION AND TREATMENT
PATIENTS 50 YEARS AND OLDER REQUIRE SCREENING COLONOSCOPY. PATIENTS WITH FAMILY HISTORY OF COLON CANCER WILL REQUIRE IT BEFORE THE AGE OF 50.
Drug: AB PREP
Potassium phosphate and Sodium Phosphate,(in the form of K-phos neutral 8 tablets.(Bisacodyl)6tablets. The third medication is (Metoclopramide).
Other Names:
  • Reglan, K-Phos neutral, and Dulcolax

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
TOTAL COLON CLEANSING, TO BE ABLE TO PERFORM COLONOSCOPY
Time Frame: IMMEDIATE, DURING THE COLONOSCOPY
IMMEDIATE, DURING THE COLONOSCOPY

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Long Neck Medical Enterprises

Collaborators

National Institutes of Health (NIH)

Investigators

  • Principal Investigator: SEMAAN M ABBOUD, MD

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2009

Primary Completion (Anticipated)

January 1, 2010

Study Completion (Anticipated)

January 1, 2010

Study Registration Dates

First Submitted

January 5, 2009

First Submitted That Met QC Criteria

January 6, 2009

First Posted (Estimate)

January 7, 2009

Study Record Updates

Last Update Posted (Estimate)

January 7, 2009

Last Update Submitted That Met QC Criteria

January 6, 2009

Last Verified

January 1, 2009

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ABBPREP1
  • AB1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colon Cancer

Clinical Trials on AB PREP

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe